After an encouraging start, the AIM Index floundered around the US open although hopes that UK rate hikes may now be on hold offered a degree of support. The All Share managed to finish the session just a quarter of a point higher at 695.92.
- Induction Healthcare +27%
- Windward +16%
- Oncimmune +14%
- Safestyle -31%
- Versarien -20%
Induction Healthcare LON:INHC added 27% on the day, extending gains seen earlier in the week off the back of news that the company had signed three NHS contracts for the delivery of portals. The stock has almost doubled in value since the start of the week although there appears to be a shortage of sellers, something that has contributed to a spread exceeding 20%.
Windward LON:WNWD was in second place, up 16%. The company this morning issued a note highlighting contract wins and renewals as underpinning growth in the second half of the year and putting the maritime AI company on course to meet expectations for the full year.
Oncimmune LON:ONC gets the notable mention, up 14% following a strategy update and news of a boardroom reshuffle. Critically the company is now focused on higher value customers and doesn’t see the need for any material CAPEX as a result.
- AIM Market Roundup: Tungsten West, Savannah Energy, Team Internet Group
- UK Stock Market News: Oncimmune, B&M, National Grid
- UK Stock Market News: Tritax, Oncimmune, Smiths
Safestyle LON:SFE was at the foot of the table, with the company remaining under pressure following news that Interpath Advisory had been engaged by the business as it looks to find a way to shore up its finances. At present bankers remain supportive but the risk is clearly that equity holders could find themselves offside as a result.
And Versarien LON:VRS was in second to last place, following news of a general meeting to allow it to reclassify share holdings to remain in line with UK companies regulations. The company’s stock has had a rough ride in recent years having traded close to the £2 level in 2018 before now sitting sub-1p.
